NO983332L - Gas bubble suspensions and their use as an ultrasonic contrast agent - Google Patents
Gas bubble suspensions and their use as an ultrasonic contrast agentInfo
- Publication number
- NO983332L NO983332L NO983332A NO983332A NO983332L NO 983332 L NO983332 L NO 983332L NO 983332 A NO983332 A NO 983332A NO 983332 A NO983332 A NO 983332A NO 983332 L NO983332 L NO 983332L
- Authority
- NO
- Norway
- Prior art keywords
- contrast agent
- gas bubble
- ultrasonic contrast
- bubble suspensions
- suspensions
- Prior art date
Links
- 239000002961 echo contrast media Substances 0.000 title abstract 2
- 239000000725 suspension Substances 0.000 title abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
- C08J9/14—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
- C08J9/143—Halogen containing compounds
- C08J9/147—Halogen containing compounds containing carbon and halogen atoms only
- C08J9/148—Halogen containing compounds containing carbon and halogen atoms only perfluorinated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
- A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
- A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
- C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
- C08J9/14—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
- C08J9/143—Halogen containing compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2300/00—Characterised by the use of unspecified polymers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acoustics & Sound (AREA)
- Physics & Mathematics (AREA)
- Radiology & Medical Imaging (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Oppfinnelsen angår porøse matrikser av lavmolekylære substanser for dannelse av stabile gassboblesuspensjoner, deres anvendelse som ultralydkontrastmiddel og fremgangsmåte for fremstilling av matrikser og middel.The invention relates to porous matrices of low molecular weight substances for the formation of stable gas bubble suspensions, their use as ultrasonic contrast agent and to the method of preparation of matrices and agents.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19602930A DE19602930A1 (en) | 1996-01-18 | 1996-01-18 | Porous matrices made of low molecular weight substances for the generation of stable gas bubble suspensions, their use as ultrasound contrast agents and processes for their production |
PCT/EP1997/000208 WO1997026016A2 (en) | 1996-01-18 | 1997-01-16 | Gas bubble suspensions and their application as an ultrasound contrast medium |
Publications (2)
Publication Number | Publication Date |
---|---|
NO983332L true NO983332L (en) | 1998-07-17 |
NO983332D0 NO983332D0 (en) | 1998-07-17 |
Family
ID=7783852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO983332A NO983332D0 (en) | 1996-01-18 | 1998-07-17 | Gas bubble suspensions and their use as an ultrasonic contrast agent |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0874644A2 (en) |
JP (1) | JP2000504317A (en) |
AU (1) | AU1592597A (en) |
CA (1) | CA2243174A1 (en) |
DE (1) | DE19602930A1 (en) |
NO (1) | NO983332D0 (en) |
WO (1) | WO1997026016A2 (en) |
ZA (1) | ZA97414B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070123478A1 (en) * | 2005-11-28 | 2007-05-31 | Rowe Vernon D | Compositions useful for reducing nephrotoxicity and methods of use thereof |
JP5196896B2 (en) * | 2007-07-13 | 2013-05-15 | 花王株式会社 | Method for producing fine bubble precursor |
JP2010005512A (en) * | 2008-06-25 | 2010-01-14 | Kao Corp | Microbubble precursor composition |
KR101927614B1 (en) | 2017-03-30 | 2018-12-10 | 숭실대학교산학협력단 | Preparing method of contrast agent with stable oxygen-nanobubble or ultrasound imaging |
JP7211699B2 (en) * | 2017-09-11 | 2023-01-24 | バイエル ファーマ アクチエンゲゼルシャフト | Ultrasound contrast agent |
US20240226418A1 (en) * | 2021-01-26 | 2024-07-11 | Agitated Solutions Inc. | Syringe-Based Microbubble Generator |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3141641A1 (en) * | 1981-10-16 | 1983-04-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | ULTRASONIC CONTRAST AGENTS AND THEIR PRODUCTION |
DE3834705A1 (en) * | 1988-10-07 | 1990-04-12 | Schering Ag | ULTRASONIC CONTRASTING AGENTS FROM GAS BUBBLES AND MICROPARTICLES CONTAINING FATTY ACID |
DE3313946A1 (en) * | 1983-04-15 | 1984-10-18 | Schering AG, 1000 Berlin und 4709 Bergkamen | MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS |
DE3313947A1 (en) * | 1983-04-15 | 1984-10-18 | Schering AG, 1000 Berlin und 4709 Bergkamen | MICROPARTICLES AND GAS BUBBLES CONTAINING ULTRASONIC CONTRASTING AGENTS |
DE3709851A1 (en) * | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | NMR DIAGNOSTIC LIQUID COMPOSITIONS |
US5445813A (en) * | 1992-11-02 | 1995-08-29 | Bracco International B.V. | Stable microbubble suspensions as enhancement agents for ultrasound echography |
US5147631A (en) * | 1991-04-30 | 1992-09-15 | Du Pont Merck Pharmaceutical Company | Porous inorganic ultrasound contrast agents |
ATE151992T1 (en) * | 1991-06-03 | 1997-05-15 | Nycomed Imaging As | IMPROVEMENTS REGARDING CONTRAST AGENTS |
EP0593627A1 (en) * | 1991-07-05 | 1994-04-27 | The University Of Rochester | Ultrasmall non-aggregated porous particles entrapping gas-bubbles |
AU675050B2 (en) * | 1991-07-05 | 1997-01-23 | Nycomed Imaging As | Improvements in or relating to contrast agents |
RU2114637C1 (en) * | 1991-09-17 | 1998-07-10 | Сонус Фармасьютикалз, Инк. | Biologically compatible contrast medium and method for producing ultrasonic images |
GB9200388D0 (en) * | 1992-01-09 | 1992-02-26 | Nycomed As | Improvements in or relating to contrast agents |
IL104084A (en) * | 1992-01-24 | 1996-09-12 | Bracco Int Bv | Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them |
US5798091A (en) * | 1993-07-30 | 1998-08-25 | Alliance Pharmaceutical Corp. | Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement |
EP1550464A1 (en) * | 1993-07-30 | 2005-07-06 | IMCOR Pharmaceutical Co. | Stabilized microbubble composition for ultrasound |
PL182223B1 (en) * | 1993-12-15 | 2001-11-30 | Bracco Research Sa | Usg contrast medium |
GB9402867D0 (en) * | 1994-02-15 | 1994-04-06 | Nycomed Imaging As | Improvements in or relating to contrast agents |
DE4406474A1 (en) * | 1994-02-23 | 1995-08-24 | Schering Ag | Gas-containing microparticles, agents containing them, their use in ultrasound diagnostics, and methods for producing the particles and agents |
-
1996
- 1996-01-18 DE DE19602930A patent/DE19602930A1/en not_active Withdrawn
-
1997
- 1997-01-16 AU AU15925/97A patent/AU1592597A/en not_active Abandoned
- 1997-01-16 WO PCT/EP1997/000208 patent/WO1997026016A2/en not_active Application Discontinuation
- 1997-01-16 CA CA002243174A patent/CA2243174A1/en not_active Abandoned
- 1997-01-16 JP JP9525697A patent/JP2000504317A/en active Pending
- 1997-01-16 EP EP97902178A patent/EP0874644A2/en not_active Withdrawn
- 1997-01-17 ZA ZA97414A patent/ZA97414B/en unknown
-
1998
- 1998-07-17 NO NO983332A patent/NO983332D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0874644A2 (en) | 1998-11-04 |
WO1997026016A2 (en) | 1997-07-24 |
ZA97414B (en) | 1997-07-17 |
DE19602930A1 (en) | 1997-07-24 |
CA2243174A1 (en) | 1997-07-24 |
WO1997026016A3 (en) | 1997-10-23 |
AU1592597A (en) | 1997-08-11 |
NO983332D0 (en) | 1998-07-17 |
JP2000504317A (en) | 2000-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20030374L (en) | Cyclopentanoindoles, preparations containing such compounds and treatment methods | |
DK1100344T3 (en) | Chitosan-containing liquid preparations and methods for their preparation and use | |
CY1106008T1 (en) | MEMBRANE FORMING COMPOSITIONS EMBRACE MODIFIED STARCHES AND IOTA-CARRAGEENAN AND METHODS OF MAKING SOFT CAPSULES USING THEM | |
CY1107319T1 (en) | METHOD FOR CLEANING BACTERIAL CELLS AND CELLULAR INGREDIENTS | |
DK1076657T3 (en) | New hydroxy indoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation | |
TR200000782T2 (en) | Resorcinol derivatives. | |
TR200100922T2 (en) | Application of active substances through the lungs. | |
ID29642A (en) | Porous sheets, absorbent objects that use porous sheets and the method of making them | |
DK0922045T3 (en) | Bicyclic pyrimidine derivatives and their use as anticoagulants | |
ECSP034859A (en) | NEW PIRROL DERIVATIVES AS PHARMACEUTICAL AGENTS | |
DE69514661D1 (en) | POLYMERIZATION CATALYST SYSTEM, THEIR PRODUCTION AND USE | |
DE69942459D1 (en) | ISOLATED NUCLEIC ACID MOLECULES COPYING T CELLS INDUCIBLE FACTORS (TIF), ENCODING PROTEINS AND THEIR USE | |
ATE229007T1 (en) | 6-BENZYL-2H-PYRIDAZINE-3-ONE DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS INHIBITORS OF PROSTAGLANDIN G/H SYNTHASE I AND II (COX I AND COX II) | |
DE60035032D1 (en) | USE OF PIOGLITAZONE FOR THE IMPROVEMENT OF KETOSIS AND AZIDOSIS | |
NO20012977D0 (en) | N-ureidoalkylpiperidines as modulators of chemokine receptor activity | |
DK1097173T3 (en) | Use of IL-2 peptides and derivatives thereof as therapeutic agents | |
ATE217155T1 (en) | HOMOGENEOUS AND STABLE SUSPENSION WITHOUT EMULSIFIERS, METHOD FOR THE PRODUCTION THEREOF AND ITS USE IN FOOD COMPOSITIONS | |
EE05091B1 (en) | Oligosaccharides, process for their preparation and use, and pharmaceutical compositions | |
BR0115354A (en) | Stable liquid suspension compositions, method of preparation and use thereof | |
NO983332L (en) | Gas bubble suspensions and their use as an ultrasonic contrast agent | |
BR0114379A (en) | Substituted c-cyclohexylmethylamine derivatives | |
NO20010568D0 (en) | Substituted imidazo [1,2a] azines as selective inhibitors of cox-2 | |
BRPI0507987A (en) | glucocorticoid receptor modulating methods and compounds | |
DK0556322T3 (en) | Aminosulfonylurinstof-ACAT inhibitors | |
NO20044446L (en) | Use of polymers comprising thermoplastic polymers as filter aids and / or stabilizers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |